Pöppelmann GmbH & Co. KG (FAMAC/KAPSTO)
Is this your company? Claim this profile
Drug Product
Manufacturing & Lab Equipment
Company Overview
About
Pöppelmann GmbH & Co. KG (FAMAC/KAPSTO) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Neurology
Quick Facts
HQ:Germany
Founded:1999
Employees:1,171
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Global
Regulatory Approvals
Drug Approval 3J7N34
Health Canada · #APR-S3PDNMHW · 2019-10-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-CAVQCHP1
Issued: 2020-09-02
Expires: 2025-09-09
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-CL4OW0V0
Issued: 2020-06-17
Expires: 2025-09-03
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-SJELBEI6
Issued: 2020-09-14
Expires: 2025-08-18
Loading CDMO intelligence...
Key facts about Pöppelmann GmbH & Co. KG (FAMAC/KAPSTO)
- Pöppelmann GmbH & Co. KG (FAMAC/KAPSTO) is headquartered in Germany.
- Pöppelmann GmbH & Co. KG (FAMAC/KAPSTO) was founded in 1999.
- Pöppelmann GmbH & Co. KG (FAMAC/KAPSTO) has 1,171 employees.
- Pöppelmann GmbH & Co. KG (FAMAC/KAPSTO)'s capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Pöppelmann GmbH & Co. KG (FAMAC/KAPSTO)
Directory pages this company appears in, each with the full list of matching manufacturers.